Buscar
Mainz Biomed NV
MYNZAñadir a la lista de seguimiento
0.844USD
0.0000.00%
Cierre 07/01, 16:00（ET）Cotizaciones retrasadas 15 min
35.06MCap. mercado
PérdidaP/E TTM
Más Datos de Mainz Biomed NV Compañía
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
Información de Mainz Biomed NV
Símbolo de cotizaciónMYNZ
Nombre de la empresaMainz Biomed NV
Fecha de salida a bolsaNov 04, 2021
Director ejecutivoBaechler (Guido)
Número de empleados19
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 04
DirecciónSirius Gutenberg Park
CiudadMAINZ
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísGermany
Código postal55129
Teléfono496131265140
Sitio Webhttps://www.mainzbiomed.com/
Símbolo de cotizaciónMYNZ
Fecha de salida a bolsaNov 04, 2021
Director ejecutivoBaechler (Guido)
Ejecutivos de Mainz Biomed NV
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
64.50K
+96.59%
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
56.00K
+68.27%
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
55.88K
+17.90%
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36K
-9410.50%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+93.24%
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
64.50K
+96.59%
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
56.00K
+68.27%
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
55.88K
+17.90%
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36K
-9410.50%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+93.24%
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Mainz Biomed NV?
Los cinco principales accionistas de Mainz Biomed NV son: Dr. Heiner Dreismann, Ph.D.
¿Cuántas instituciones poseen acciones de Mainz Biomed NV (MYNZ)?
A fecha de 2026Q1, 33 instituciones poseen acciones de Mainz Biomed NV, con un valor de mercado combinado de aproximadamente 1.23M, lo que representa el 9.84% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 663009.00.